Jinhe Biotechnology CO., LTD. (002688.SZ)
- Previous Close
3.7900 - Open
3.6000 - Bid 3.8100 x --
- Ask 3.8200 x --
- Day's Range
3.7400 - 3.8500 - 52 Week Range
2.9100 - 5.2100 - Volume
9,906,478 - Avg. Volume
14,345,286 - Market Cap (intraday)
2.981B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
38.20 - EPS (TTM)
0.1000 - Earnings Date --
- Forward Dividend & Yield 0.10 (2.62%)
- Ex-Dividend Date Jun 5, 2023
- 1y Target Est
--
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD. was founded in 1990 and is based in Dalian, China.
www.jinhe.com.cn2,292
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 002688.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002688.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002688.SZ
Valuation Measures
Market Cap
2.98B
Enterprise Value
4.60B
Trailing P/E
39.14
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.45
Price/Book (mrq)
1.31
Enterprise Value/Revenue
2.23
Enterprise Value/EBITDA
32.21
Financial Highlights
Profitability and Income Statement
Profit Margin
3.70%
Return on Assets (ttm)
1.65%
Return on Equity (ttm)
3.53%
Revenue (ttm)
2.06B
Net Income Avi to Common (ttm)
76.15M
Diluted EPS (ttm)
0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
683.2M
Total Debt/Equity (mrq)
90.41%
Levered Free Cash Flow (ttm)
-299.47M
Research Analysis: 002688.SZ
Company Insights: 002688.SZ
002688.SZ does not have Company Insights